FundedIQ
Biotechnology

CellVax Therapeutics Inc.: Funding, Investors & Team (Sep 2026)

CellVax Therapeutics is a privately-held clinical-stage company developing autologous anticancer vaccines

www.cellvx.com Miami, United States 1-10 employees
Total raised
$2.1M
Rounds
1
Latest
Undisclosed round
Oct 2024

CellVax Therapeutics Inc. has raised $2.1M across 1 funding round on record, the most recent an undisclosed round of $2.1M announced in Oct 2024.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

CellVax Therapeutics Inc. Company Profile and Key Stats

Total funding raised
$2.1M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$2.1M in Oct 2024
Employees
1-10
reported band
Headquarters
Miami, United States

Latest funding round on record: Oct 2024.

CellVax Therapeutics Inc. Funding Rounds

Date
Round
Amount
Undisclosed round
$2.1M

CellVax Therapeutics Inc. Founders and Leadership Team

Name
Role
Contact
Fernando Kreutz
Founder
Locked

Contact details for the CellVax Therapeutics Inc. team: 1 of 1 has an email address on file.

Start 14-day free trial →

CellVax Therapeutics Inc. Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,183
$8.0M
29,878
$7.5M

CellVax Therapeutics Inc.'s latest round of $2.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like CellVax Therapeutics Inc. in Biotechnology and Miami

Companies Similar to CellVax Therapeutics Inc.

SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…

Undisclosed round $960k

DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…

Series B $4.0M

Solstice Oncology is a clinical stage immuno-oncology company

Series A $225M

Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…

Series F $275M

BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…

Series A $116M

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

CellVax Therapeutics Inc. Funding FAQs

What does CellVax Therapeutics Inc. do?

CellVax Therapeutics is a privately-held clinical-stage company developing autologous anticancer vaccines

How much funding has CellVax Therapeutics Inc. raised?

CellVax Therapeutics Inc. has raised $2.1M across 1 round on record. The most recent is an undisclosed round of $2.1M announced in Oct 2024.

When did CellVax Therapeutics Inc. last raise funding?

CellVax Therapeutics Inc.'s most recent funding round on record is an undisclosed round of $2.1M, announced in Oct 2024.

Who founded CellVax Therapeutics Inc.?

FundedIQ lists Fernando Kreutz (Founder) at CellVax Therapeutics Inc..

Where is CellVax Therapeutics Inc. headquartered?

CellVax Therapeutics Inc. is based in Miami, Florida, United States.

How many employees does CellVax Therapeutics Inc. have?

CellVax Therapeutics Inc. is in the 1-10 employee band.

How does CellVax Therapeutics Inc.'s funding compare to other Biotechnology startups?

CellVax Therapeutics Inc.'s latest round of $2.1M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.

About FundedIQ's CellVax Therapeutics Inc. Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CellVax Therapeutics Inc. is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.